Please try another search
Parnell Pharmaceuticals Holdings Ltd is an Australia-based fully integrated, commercial-stage pharmaceutical company. The Company is focused on developing, manufacturing and marketing animal health solutions. It markets products for companion, performance and production animals enhanced with software platforms designed to improve compliance and clinical outcomes. It markets cattle breeding programs as well as osteoarthritis solutions for dogs and horses. The Company's companion animal products include GLYDE Mobility Chews and ZYDAX Injection. Its reproduction product portfolio includes GONAbreed, estroPLAN and Parnell PROcept. Its performance products include ZYDAX and GLYDE. GLYDE Mobility Chews offer a solution that controls the clinical signs of arthritis in dogs, and aids in improvement of joint health and function. The Company is also focused on developing mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains.
Name | Age | Since | Title |
---|---|---|---|
Brad R. McCarthy | 45 | 2010 | CEO, CFO, Chief Accounting Officer, Company Secretary & Executive Director |
Alan Richard Bell | 65 | 2006 | Executive Chairman |
Eric Moore | - | 2020 | Independent Director |
John B. Benear | - | 2020 | Independent Director |
Douglas K. Schillinger | - | 2020 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review